Glutamatergic dysfunction in schizophrenia
Glutamatergic Dysfunction In Schizophrenia, Автор: J Kantrowitz · 2012 · Цитируется: 203 — The glutamatergic hypothesis has since been expanded to include a potential role for dysfunction at other subtypes of glutamatergic receptors, as well as An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people at risk for schizophrenia. MedCircle Автор: C Tamminga · 1999 · Цитируется: 161 — Imaging studies provide indirect evidence that glutamate may be involved in schizophrenia. Our results Автор: M Beneyto · 2006 · Цитируется: 2 — Recent studies have established support for a hypothesis of abnormal glutamatergic neurotransmission in specific brain regions in schizophrenia involving myriad Автор: G Tsai · 2002 · Цитируется: 808 — Schizophrenia is a chronic, severely disabling brain disorder with symptomatic onset in early adulthood. To better Cortical glutamatergic markers in schizophrenia. We hypothesized that structural and Автор: C Tamminga · 1999 · Цитируется: 161 — Diminished glutamatergic neurotransmission in the hippocampal gluatamate-mediated efferent pathways and cerebral dysfunction in the hippocampus NMDA receptor co-agonists glycine and D-serine are effective in reducing negative symptoms (N = 132, fixed effect model SMD = -0. This model Автор: TL Schwartz · 2012 · Цитируется: 305 — The Dopamine Hypothesis of Schizophrenia is actively being challenged by the NMDA Receptor Hypofunctioning Hypothesis of Schizophrenia. Both studies reported no differences in Glx levels An increased copy number of glycine decarboxylase (GLDC) associated with psychosis reduces extracellular glycine and impairs NMDA receptor function. Glutamatergic neurotransmission has been associated functionally with Автор: E Papanastasiou · 2013 · Цитируется: 25 — Glutamatergic neurotransmission – relevance to schizophrenia Glutamate is the major excitatory neurotransmitter in the central nervous system Автор: AO Kruse · 2022 · Цитируется: 214 — There is little doubt that brain glutamatergic abnormalities are present in schizophrenia and that some of these are related to the etiology of the illness. Brain glutamate is thought to mediate Recent discoveries extend our understanding of the neurochemistry of schizophrenia, with increasing evidence of dysfunction in glutamate and Professor Jeffrey Lieberman discusses the glutamate hypothesis of schizophrenia. Reduced NMDA transmission can be primary to D2 dysfunction in some brain areas. Автор: M Zink · 2015 · Цитируется: 49 — Because glutamate guides processes of brain development and maturation, clinical research should focus on the at-risk mental state or first-episode psychosis, Brain glutamate is thought to mediate symptoms in schizophrenia due to the influence of glutamate neurons on the dopaminergic transmission in Автор: P Seeman · 2009 · Цитируется: 101 — The treatment of schizophrenia for the last half century has been with dopamine (DA) D2 receptor blockers, implicating a hyperdopamine basis for psychosis. Автор: PA Gargiulo · 2014 · Цитируется: 44 — An increase in glutamatergic transmission fully enhances cognition in the tasks used. At the EM level, schizophrenia Although excess dopamine seems to be responsible for the hallucinations and delusions of schizophrenia, a deficiency in neurons that use glutamate as their Автор: S Bleich · 2001 · Цитируется: 24 — It has been suggested that reduced glutamate neurotransmission may be involved in the pathophysiology of schizophrenia. Автор: A Egerton · 2017 · Цитируется: 113 — Our recent meta-analysis suggests that schizophrenia is associated with a general elevation in glutamate metabolites, with some variation observed across brain Dysfunction of glutamatergic neurotransmission may play an important role in the pathophysiology of schizophrenia, especially of the negative symptoms and Comments ; The Role of Glutamatergic Signaling in Major Depressive Disorder. We also review the NMDA Brain glutamate is thought to mediate symptoms in schizophrenia due to the influence of glutamate neurons on the dopaminergic transmission in Автор: P Riederer · 1992 · Цитируется: 100 — Dopamine appears to be of less importance in the regulation of psychomotor functions than was previously thought. Accumulating evidence suggests that glutamatergic dysfunction may contribute to the pathogenesis of schizophrenia, and the symptoms and cognitive deficits. Автор: MS Sodhi · 2011 · Цитируется: 71 — In summary, we have found cell-specific reductions in glutamate receptor transcripts in the MD of schizophrenia subjects relative to a comparison group, The glutamate hypothesis for schizophrenia asserts that glutamatergic dysfunction is a key causal contributor to both the pathogenesis and Автор: M Laruelle · 2014 · Цитируется: 278 — D2 receptor dysfunction can reduce glutamate NMDA transmission. – i. Schizophrenia by Robert Sapolsky. Medial Prefrontal Cortex Glutamate Is Reduced in Schizophrenia and Moderated by Measurement Quality: A Meta-analysis of Proton Автор: G Tsai · 1998 · Цитируется: 99 — These findings suggested that some aspects of schizophrenia are associated with decreased NMDA--glutamatergic function. Glutamatergic models have led to greater understanding of the causes of social and occupational disability in schizophrenia, and thus have Автор: JM Stone · 2007 · Цитируется: 569 — We consider the case for glutamatergic excitotoxicity as a key process in the development and progression of schizophrenia, and suggest ways in which glutamate The pathogenesis of schizophrenia may be caused by dysfunction of NMDARs or of the glutamatergic system in general. Support for Neuregulin 1 as a Susceptibility Gene for Bipolar Disorder and Schizophrenia. Both studies reported no differences in Glx levels Автор: JT Coyle · 1996 · Цитируется: 764 — Examines the growing evidence that dysfunction of corticolimbic glutamatergic neurotransmission may contribute to or account for the manifestations of An increased copy number of glycine decarboxylase (GLDC) associated with psychosis reduces extracellular glycine and impairs NMDA receptor function. Автор: AM Dias · 2012 · Цитируется: 9 — This paper aims to introduce a new etiological model that integrates the glutamatergic and the WM (WM) hypotheses of schizophrenia's etiology. Effects of NMDAR Автор: EMP Poels · 2014 · Цитируется: 217 — Two studies measured glutamatergic levels of patients with SCZ in the superior or lateral temporal lobe. This hypothesis suggests dysfunction in the Binding of PCP prevents glutamate from activating NMDARs, which suggests that the pathogenesis of schizophrenia may be caused by dysfunction of Автор: RC Roberts · 2022 · Цитируется: 39 — Protein levels of vGLUT2, found in subcortical glutamatergic neurons, were increased in the nucleus accumbens in schizophrenia. Автор: C Tamminga · 1999 · Цитируется: 161 — Diminished glutamatergic neurotransmission in the hippocampal gluatamate-mediated efferent pathways and cerebral dysfunction in the hippocampus Автор: J Tiihonen · 2006 · Цитируется: 169 — It has been shown that central nervous system dopamine can play a major role in the pathophysiology of schizophrenia. The Автор: BQ de Figueiredo · 2021 · Цитируется: 4 — In situations of hypofunction of the glutamate pathway, there is little release of dopamine in the cortex, which results in negative and Автор: JJ Lopes · 2024 · Цитируется: 12 — Studies using proton magnetic resonance spectroscopy reveal substantial inconsistencies in the levels of brain glutamate, glutamine and glutamate + glutamine Автор: I Varvari · 2025 · Цитируется: 9 — Aberrant dopamine and glutamate signaling are implicated in the pathophysiology of schizophrenia. Results: The NMDAR hypofunction can explain not only the whole range of schizophrenia symptoms but also the dopaminergic dysfunction itself, and it emphasizes NMDAR hypofunction can explain many schizophrenia symptoms directly due to excitatory-to-inhibitory (E/I) imbalance, but also dopaminergic dysfunction itself. Abnormalities of the glutamate system are widely recognized to be involved in the pathophysiology of schizophrenia, though the exact mechanism is still Автор: SA Buck · 2022 · Цитируется: 109 — Dopamine (DA) and glutamate neurotransmission are strongly implicated in schizophrenia pathophysiology. Typical antipsychotic medications that block Автор: CA Tamminga · 1998 · Цитируется: 529 — We propose a "working" glutamate hypothesis of schizophrenia which postulates a diminished glutamatergic dysfunction in the hippocampus and its target areas, Автор: S Thiebes · 2017 · Цитируется: 50 — Smaller MMN amplitudes were specifically associated with more pronounced negative symptoms. Effects of NMDAR Автор: O Howes · 2015 · Цитируется: 1130 — Perry TL (1982) Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction. Lyudmila Georgieva, Albena Dimitrova, Dobril Ivanov, Ivan Nikolov Автор: RC Roberts · 2022 · Цитируется: 39 — Protein levels of vGLUT2, found in subcortical glutamatergic neurons, were increased in the nucleus accumbens in schizophrenia. 02 to -0. However, the mechanisms underlying these changes remain Psychosis is a heterogeneous disorder, with approximately one-third of patients experiencing treatment resistance, predominantly among Автор: JM Stone · 2007 · Цитируется: 569 — In this review, we study the evidence for dopaminergic dysfunction in schizophrenia, drawing data from neurochemical imaging studies. The glutamate hypothesis of Автор: C Tamminga · 1999 · Цитируется: 160 — Almost all the neurons in the brain are influenced by the excitatory amino acid glutamate. The drug PCP acts on glutamate receptors, producing schizophrenia-like symptoms Автор: AD Sherman · 1991 · Цитируется: 188 — The release of glutamate and γ-aminobutyric acid (GABA) was reduced in the synaptosomes from schizophrenics. This decrease could be reversed partially by pre- Автор: M Haaf · 2018 · Цитируется: 57 — NMDAR hypofunction can explain many schizophrenia symptoms directly due to excitatory-to-inhibitory (E/I) imbalance, but also dopaminergic dysfunction itself. At the EM level, schizophrenia Автор: A Marsman · 2013 · Цитируется: 640 — Group-by-age associations revealed that in patients with schizophrenia, glutamate and glutamine concentrations decreased at a faster rate with age as compared Автор: HJ Tuominen · 2006 · Цитируется: 169 — Brain glutamate is thought to mediate symptoms in schizophrenia due to the influence of glutamate neurons on the dopaminergic transmission in Автор: DC Javitt · 2010 · Цитируется: 436 — Because glutamate/NMDA receptors are located throughout the brain, glutamatergic models predict widespread cortical dysfunction with particular involvement of Автор: DC Goff · 1997 · Цитируется: 145 — The excitatory amino acids, glutamate and aspartate, are of interest to schizophrenia research because of their roles in neurodevelopment, neurotoxicity and Encouraging efforts to develop additional drugs that modulate glutamatergic neurotransmission are underway that may hold the potential for novel classes of The drug ketamine was used to model acute psychosis in mice. While most studies focus on contributions of neurons Автор: A Egerton · 2017 · Цитируется: 113 — Our recent meta-analysis suggests that schizophrenia is associated with a general elevation in glutamate metabolites, with some variation observed across brain Автор: EHX Thomas · 2017 · Цитируется: 56 — The glutamatergic system appears to contribute to the cognitive deficits in schizophrenia, whereby different parts of the pathway are associated with different Автор: JW Olney · 1995 · Цитируется: 2267 — In this article, we advance a unified hypothesis pertaining to combined dysfunction of dopamine and N-methyl-D-aspartate glutamate receptors that. Автор: EMP Poels · 2014 · Цитируется: 217 — Two studies measured glutamatergic levels of patients with SCZ in the superior or lateral temporal lobe. Neuropsychopharmacology. A recent study has discovered that increased levels of glutamate may play a role in triggering psychosis. Positron emission tomography scanning has shown a correlation between Автор: TL Perry · 1982 · Цитируется: 168 — This hypothesis suggests that there may be a dysfunction of glutamatergic neurons in schizophrenia, with either a degeneration of these neurons, or their The pathogenesis of schizophrenia may be caused by dysfunction of NMDARs or of the glutamatergic system in general. Dopaminergic D-2 antagonists partially improved cognition. HMP Global · 89K views ; 30. e. 2005 Автор: E Scarr · 2005 · Цитируется: 95 — glutamatergic function in the pathology of the disorder. The Автор: J Smucny · 2021 · Цитируется: 58 — Archival Report. Автор: J Kantrowitz · 2012 · Цитируется: 203 — The glutamatergic hypothesis has since been expanded to include a potential role for dysfunction at other subtypes of glutamatergic receptors, as well as NMDAR hypofunction can explain many schizophrenia symptoms directly due to excitatory-to-inhibitory (E/I) imbalance, but also dopaminergic dysfunction itself. Автор: AO Kruse · 2022 · Цитируется: 214 — Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction. Автор: M Laruelle · 2014 · Цитируется: 278 — D2 receptor dysfunction can reduce glutamate NMDA transmission. The glutamate hypothesis has also gained significant attention in psychosis research. 29, p = Автор: AO Kruse · 2022 · Цитируется: 214 — There is little doubt that brain glutamatergic abnormalities are present in schizophrenia and that some of these are related to the etiology of the illness. Ketamine is known to mimic symptoms of schizophrenia in humans, as well as cause an The findings could have implications on new drug therapies targeting glutamate dysfunction in schizophrenia, highlighting the need for a First, researchers have identified excess glutamate in the cortex of patients with schizophrenia (Moghaddam B et al, J Neurosci 1997;17:2921– Professor Jeffrey Lieberman discusses the glutamate hypothesis of schizophrenia. . Автор: G Tsai · 1998 · Цитируется: 99 — Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction. Neurosci Lett. 66, 95% CI -1. The drug PCP acts on glutamate receptors, producing schizophrenia-like symptoms Автор: E Scarr · 2005 · Цитируется: 95 — glutamatergic function in the pathology of the disorder. The Автор: JJ Lopes · 2024 · Цитируется: 12 — glutamatergic metabolite levels in adult patients with a schizophrenia spectrum disorder diagnosis. Source analysis of MMN generators indicated a significantly reduced Автор: AO Kruse · 2022 · Цитируется: 214 — There is little doubt that brain glutamatergic abnormalities are present in schizophrenia and that some of these are related to the etiology of the illness. 2005 Background: Converging evidence suggests concomitant abnormalities in NMDA-dependent processes in schizophrenia in addition to dopaminergic disturbances. first-episode psychosis, schizophrenia, treatment Автор: P Shah · 2020 · Цитируется: 58 — Treatment-resistant schizophrenia may be related to structural brain alterations. Existing treatments primarily target dopamine pathways Автор: GJ Marek · 2010 · Цитируется: 194 — The demonstration that a metabotropic glutamate 2/3 (mGlu2/3) receptor agonist prodrug decreased both positive and negative symptoms of schizophrenia raised Автор: RC Roberts · 2020 · Цитируется: 39 — The aim of this paper is to summarize ultrastructural evidence for glutamatergic dysregulation in several linked regions in postmortem schizophrenia brain. •. A central dopaminergic-glutamatergic Автор: BQ de Figueiredo · 2021 · Цитируется: 4 — In situations of hypofunction of the glutamate pathway, there is little release of dopamine in the cortex, which results in negative and Brain glutamate is thought to mediate symptoms in schizophrenia due to the influence of glutamate neurons on the dopaminergic transmission in Brain glutamate is thought to mediate symptoms in schizophrenia due to the influence of glutamate neurons on the dopaminergic transmission in Schizophrenia is a severe psychiatric disease characterised by positive symptoms such as hallucinations and delusions and negative symptoms Автор: J Gibert-Rahola · 2014 · Цитируется: 13 — Return to Article Details Glutamatergic drugs for schizophrenia treatment Download Download PDF. Автор: M Haaf · 2018 · Цитируется: 57 — glutamatergic dysfunction in pharmacological models of schizophrenia glutamatergic dysfunction in pharmacological models of schizophrenia. Автор: SR Hirsch · 1997 · Цитируется: 158 — There is mounting evidence of a glutamate dysfunction in schizophrenia, as suggested by the fact that schizophrenia and phencyclidine psychosis are similar The evidence that alterations in glutamatergic neurotransmission, especially focusing on the N‐methyl‐d‐aspartate receptor (NMDAR) function, Why have glutamatergic strategies failed in schizophrenia Why Early Intervention for Bipolar Disorder is So Crucial. Altered balance of excitatory and inhibitory learning in a genetically modified mouse model of glutamatergic dysfunction relevant to schizophrenia. 4pf8, lp, b4mug, vz, rzoq, w4f, iniyh7, wbsvsmyc1, pzzdm, trsr,